Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Calyxt Files For Mixed-Securities Shelf Offering Of Up To $50M

-Reuters

byMichael Horton

September 19, 2022

1 minute read

-Reuters

HC Wainwright & Co. Maintains Buy on Deciphera Pharmaceuticals, Lowers Price Target to $25

By Benzinga Newsdesk

Today, 7:36 AM

HC Wainwright & Co. analyst Andrew Fein maintains Deciphera Pharmaceuticals (NASDAQ:DCPH) with a Buy and lowers the price target from $70 to $25.

DCPH

RBC Capital Maintains Sector Perform on Verizon Communications, Lowers Price Target to $42

By Benzinga Newsdesk

Today, 7:36 AM

RBC Capital analyst Kutgun Maral maintains Verizon Communications (NYSE:VZ) with a Sector Perform and lowers the price target from $50 to $42.

SoftBank-Backed ShipBob Raises $200M In Bain-Led Round, Gains Unicorn Status: Reuters

By Anusuya Lahiri

Today, 7:36 AM

SoftBank Group Corp (OTC:SFTBY) (OTC:SFTBF) backed cloud-based logistics platform, ShipBob, has raised $200 million in a Bain Capital Ventures…

AMZN

4 Shots Of Pfizer COVID-19 Vaccine Not Enough To Prevent Omicron Infection, Say Israeli Researchers

By Shivdeep Dhaliwal

Today, 7:36 AM

Four doses of Pfizer Inc (NYSE: PFE) and BioNTech SE’s (NASDAQ: BNTX) vaccine were not sufficient to prevent infection with the Omicron variant of COVID-19.

BNTX

Calyxt Files For Mixed-Securities Shelf Offering Of Up To $50M

Related Posts

HC Wainwright & Co. Maintains Buy on Deciphera Pharmaceuticals, Lowers Price Target to $25

RBC Capital Maintains Sector Perform on Verizon Communications, Lowers Price Target to $42

SoftBank-Backed ShipBob Raises $200M In Bain-Led Round, Gains Unicorn Status: Reuters

4 Shots Of Pfizer COVID-19 Vaccine Not Enough To Prevent Omicron Infection, Say Israeli Researchers